Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds
Combination treatment with Velcade (bortezomib) and Thalomid (thalidomide) may…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Cellectar’s Patent for Anti-cancer Compounds Includes Potential Myeloma Therapy
Cellectar Biosciences has been granted a U.S. patent for…
Longer Dosing Interval of Zoledronic Acid Found Acceptable for Bone Metastasis
Patients with bone metastasis due to multiple myeloma, breast or prostate cancer, who received…
Vickar Foundation Donates $2M for Oncology and Blood Disorders Research
The Kerry and Simone Vickar Family Foundation has…
Dendritic Cell Immunotherapy Failed to Gain Upper Hand in Relapsed, Refractory Myeloma in Study
A new type of dendritic cell-based immunotherapy triggered an…
Targeting Genetic Alterations in Multiple Myeloma May Suppress Tumor Growth, Study Suggests
Changes in gene activity in the DNA of multiple…
